Comparing timelines and evidence available to support new TB, HIV, and HCV drug approvals: The same, only different
Sign Up to like & getrecommendations! Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0271102
Abstract: Background Tuberculosis (TB), human immunodeficiency virus (HIV), and hepatitis C virus (HCV) share a global presence and propensity to disproportionately affect marginalized populations. However, over recent decades, many fewer drugs have been brought to market… read more here.
Keywords: timelines evidence; hiv hcv; approval; evidence available ... See more keywords